Vol 11, No 1 (January 26, 2022): Translational Cancer Research

Editorial

A major milestone for Translational Cancer Research: indexing in PubMed/PubMed Central
Eric Y. Chuang
Translational Cancer Research  
2022;
11
(1)
:1-2
.

Original Article

Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer
Fanyi Gan, Chuanfen Zhang, Liang Xia, Senyi Deng
Translational Cancer Research  
2022;
11
(1)
:3-13
.
A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma
Zetian Gong, Qifan Li, Jun Li, Jiaheng Xie, Wei Wang
Translational Cancer Research  
2022;
11
(1)
:14-28
.
Prognostic implications of combined high expression of CD47 and MCT1 in breast cancer: a retrospective study during a 10-year period
Yanting Sun, Shujing Liang, Tong Li, Chujie Peng, Yiting Yang, Yun Lin, Yabin Ma, Chunyan Dong
Translational Cancer Research  
2022;
11
(1)
:29-42
.
Pure laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma: a propensity score and multivariate analysis
Kai-Chi Cheng, Kit-Man Ho
Translational Cancer Research  
2022;
11
(1)
:43-51
.
Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma
Yi Liu, Xiaoling Lin, Lujiadai Xue, Yue Wen, Shuguang Wang, Xiaoyu Wang
Translational Cancer Research  
2022;
11
(1)
:52-62
.
Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiation
Song-Quan Wang, Qing Yuan, Guang-Tao Zhang, Hai-Peng Qian, Zhi-Dan Liu, Jia-Wei Wang, Hong-Qing Cai, Jing-Hai Wan
Translational Cancer Research  
2022;
11
(1)
:63-71
.
Uniportal video-assisted thoracoscopic surgery (VATS) for the treatment of early-stage lung cancer with whole pleural adhesion
Si Young Choi, Youngkyu Moon
Translational Cancer Research  
2022;
11
(1)
:72-84
.
Knockdown of EphB3 inhibits cell proliferation partly through the AKT signaling pathway and represses epithelial-mesenchymal transition in esophageal squamous cell carcinoma
Luqun Tang, Lijun Wang, Tao Yu, Tongpeng Xu, Lizhen Zhang, Yongqian Shu
Translational Cancer Research  
2022;
11
(1)
:85-98
.
A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma
Leye Yan, Junqing Lin, Kun Ke, Zhengzhong Wu, Jingyao Huang, Ning Huang, Weizhu Yang
Translational Cancer Research  
2022;
11
(1)
:99-112
.
Bone metastasis of esophageal carcinoma diagnosed as a first primary tumor: a population-based study
Rong-Chun Wang, Xiao-Long Liu, Chen Qi, Hao Chen, Yi-Yang Liu, De-Min Li, Hai-Zhu Song, Jun Yi
Translational Cancer Research  
2022;
11
(1)
:113-123
.
Association between family history and prognosis of patients with colorectal cancer: a systematic review and meta-analysis
Peiwei Li, Shuyan Li, Jiamin Chen, Liming Shao, Xinliang Lu, Jianting Cai
Translational Cancer Research  
2022;
11
(1)
:124-133
.
Patient-derived tumor spheroid cultures as a promising tool to assist personalized therapeutic decisions in breast cancer
Sarah Hofmann, Raichel Cohen-Harazi, Yael Maizels, Igor Koman
Translational Cancer Research  
2022;
11
(1)
:134-147
.
The trends and efficacy of operation in the treatment of hepatocellular carcinoma
Linxia Wu, Lei Chen
Translational Cancer Research  
2022;
11
(1)
:148-159
.
Predictive role of the monocyte-to-lymphocyte ratio in advanced hepatocellular carcinoma patients receiving anti-PD-1 therapy
Zhen-Feng Zhu, Li-Ping Zhuang, Chen-Yue Zhang, Zhou-Yu Ning, Dan Wang, Jie Sheng, Yong-Qiang Hua, Jing Xie, Li-Tao Xu, Zhi-Qiang Meng
Translational Cancer Research  
2022;
11
(1)
:160-170
.
Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study
Jianan Chen, Haipeng Chen, Fuqiang Zhao, Zheng Wang, Qian Liu
Translational Cancer Research  
2022;
11
(1)
:171-180
.
A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer
Jingyi Liu, Yuwei Ling, Ning Su, Yan Li, Siyuan Tian, Bingxin Hou, Shanquan Luo, Lina Zhao, Mei Shi
Translational Cancer Research  
2022;
11
(1)
:181-192
.
Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
Mingyu Zhu, Haiyan Cui, Lu Zhang, Kuo Zhao, Xiaochen Jia, Hao Jin
Translational Cancer Research  
2022;
11
(1)
:193-205
.
Carfilzomib inhibits the proliferation and apoptosis of multiple myeloma cells by inhibiting STAT1/COX-2/iNOS signaling pathway
Shaolong He, Weiwei Tian, Jie Zhao, Rong Gong, Tao Wang, Liangming Ma
Translational Cancer Research  
2022;
11
(1)
:206-216
.
The correlation between common postoperative complications and quality of life, serum tumor markers, and prognosis in patients with esophageal cancer
Linlin Sun, Fengqin Xu, Xiajun Xu, Chunmei Liu
Translational Cancer Research  
2022;
11
(1)
:217-226
.
Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis
Pengyi Guo, Tinghui Xu, Ying Jiang, Wenming Shen
Translational Cancer Research  
2022;
11
(1)
:227-241
.
Circular RNA circTADA2A promotes the proliferation, invasion, and migration of non-small cell lung cancer cells via the miR-450b-3p/HMGN5 signaling pathway
Jiongwei Jin, Botao Xu, Zhiyuan Hu, Xiangfeng He
Translational Cancer Research  
2022;
11
(1)
:242-251
.
Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors
Nana Huang, Chenchen Zhao, Xueyang Hu, Congjun Zhang, Fuxing Xiong, Wei Huang, Liangshan Da, Yuanyuan Shen, Hongyang Wu
Translational Cancer Research  
2022;
11
(1)
:252-261
.

Review Article

A narrative review for the Hippo-YAP pathway in cancer survival and immunity: the Yin-Yang dynamics
Ruochong Wang, Guiquan Zhu
Translational Cancer Research  
2022;
11
(1)
:262-275
.
Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review
Xiaojing Xu, Yiyi Yu, Mengling Liu, Li Liang, Tianshu Liu
Translational Cancer Research  
2022;
11
(1)
:276-287
.

Case Report

Clear cell sarcoma of the kidney in an adult: a case report and literature review
Mingxin Cao, Junlong Zhang, Huisi Ma, Yueyou Liang
Translational Cancer Research  
2022;
11
(1)
:288-294
.
Effectiveness of afatinib in an NSCLC patient with EGFR mutation and early progression to osimertinib: a case report
Koichiro Nozaki, Satoshi Watanabe, Kazuto Nishio, Kazuko Sakai, Toshiaki Kikuchi
Translational Cancer Research  
2022;
11
(1)
:295-298
.
Metastatic papillary thyroid carcinoma with no primary tumor in the thyroid gland: a case report and review of literature
Daxue Li, Jiazhen Li, Jing Zhou, Qian Xiao, Han Gao
Translational Cancer Research  
2022;
11
(1)
:299-305
.